Editorial Note: IQV at $179.17 RSI 52 — a modest pullback from May 29 ($182.21, RSI 61.8). -6.15% over 7D but +3.68% over 30D; price is now just +0.6% above SMA20 ($178.18), essentially at the moving average. RSI 52 is neutral — the constructive trend improvement from April/May is consolidating rather than reversing. HELD POSITION (9 shares @ $164.63 avg) remains in-the-money at approximately +8.8% unrealized at current price. -27.48% from 52wk high still leaves substantial recovery runway. The 7D pullback (-6.15%) is notable but RSI holding above 50 and price above SMA20 are both positive. The clinical trials data analytics thesis is unchanged. Watch for SMA20 to hold as support — a clean bounce here with RSI staying above 45 would confirm the recovery trend remains intact.

2026-07-11 tape note: No contradiction — the SMA20-hold scenario the 06-16 note asked to watch for played out and then some. IQV $207.85, RSI 68.3 (approaching but not yet overbought), now +9.6% above SMA20 and +6.1% above SMA200. 30D accelerated to +14.8%, 3M to +20.85%, and the gap to the 52wk high has closed sharply to -15.87% (from -27.48%). HELD POSITION now ~+26.3% unrealized (9 shares @ $164.63 avg vs $207.85). New watch item: RSI at 68.3 is close to overbought — a fresh cooling-off leg wouldn't be surprising after this run.

2026-07-17 tape note: The cooling-off flagged as a watch item has arrived, mildly. IQV $206.26, RSI 62.4 (down from 68.3), now +4.7% above SMA20 ($197.03) — still comfortably above but off the extended reading. 7D -0.76%, 30D +22.94% (still accelerating), 3M +16.69%. -16.51% from 52wk high, essentially flat. HELD POSITION (9 shares @ $164.63 avg) still deeply in the money at current price. No new fundamentals re-researched; this is a healthy RSI reset, not a reversal.

2026-07-25 tape note (Friday 2026-07-24 close): Still firm. IQV $208.05 (+0.9% vs $206.26), RSI 61.6 (essentially flat) — +2.0% above SMA20 (narrowed from +4.7%, price consolidating closer to the average), +10.9% above SMA50, +5.8% above SMA200. 7D has flipped positive to +0.87% (from -0.76%), 30D has moderated to +12.08% (from +22.94%), and 3M has accelerated further to +28.2% (from +16.69%). -16.08% from 52wk high, essentially flat vs -16.51%. HELD POSITION (9 shares @ $164.63 avg) remains deeply in the money at current price. No new fundamentals re-researched.

2026-07-28 tape note — SHARP SINGLE-DAY MOVE: IQV $242.94 (+16.8% vs $208.05), a +13.94% single-day jump, RSI 79.1 (up sharply from 61.6, now firmly overbought — the highest reading this file has tracked). +17.4% above SMA20 (widened from +2.0%), +28.5% above SMA50, +23.4% above SMA200. 7D has jumped to +20.49% (from +0.87%), 30D to +25.69% (from +12.08%), and 3M has accelerated sharply to +55.07% (from +28.2%). -1.93% from 52wk high — essentially at new highs, a sharp improvement from -16.08%. Regime now tagged "parabolic." HELD POSITION (9 shares @ $164.63 avg) is now well further in the money. No fundamentals re-researched this cycle — no company-specific news identified here for the size of this move; treat as a sharp overbought extension, not confirmation to add at these levels. Per the full-scan summaries (2026-07-28 close). 2026-07-31 tape note: IQV $235.02 (-3.26% vs $242.94), RSI 68.2 (cooled from 79.1). 7D +12.96% (decelerated from +20.49%), 30D +15.66% (decelerated from +25.69%), 3M +48.96% (decelerated from +55.07%). From the 52-week high, the gap is -6.50% (widened from -1.93%). Per the tape: trend "up", regime "uptrend", no golden cross. No new fundamentals re-researched. Per the full-scan summaries (2026-07-31 close). 2026-08-08 tape note: IQV $238.70 (+1.57% vs $235.02), RSI 65.5 (cooled from 68.2). 7D +1.57% (moderated from +12.96%), 30D +17.13% (accelerated from +15.66%), 3M +33.57% (moderated from +48.96%). From the 52-week high, the gap is -6.09% (narrowed from -6.50%). Per the tape: trend "strong-up", regime "uptrend", golden cross intact. No new fundamentals re-researched. Per the full-scan summaries (2026-08-07 close). 2026-08-14 tape note: IQV $236.66 (-0.85% vs $238.70), RSI 61.6 (cooled from 65.5). 7D -0.85% (turned negative from +1.57%), 30D +14.43% (moderated from +17.13%), 3M +39.94% (accelerated from +33.57%). From the 52-week high, the gap is -3.91% (narrowed from -6.09%). Per the tape: trend "strong-up", regime "uptrend", golden cross intact. No new fundamentals re-researched. Per the full-scan summaries (2026-08-14 close).

Price Data (2026-08-14 tape)

Key Changes vs 2026-07-28

Research Log

Sources

• Tape data (price/RSI/SMA/returns): full-scan pre-computed summaries as of the 2026-07-31 tape — biotech-capital-cycle.
• Prior-cycle history: this file's dated update log (refreshed each full scan).